Today’s Research Reports on Trending Tickers: McDonald’s and Pfizer

NEW YORK, NY / ACCESSWIRE / January 31, 2018 / U.S. markets fell sharply Tuesday for the second consecutive day. Both the Dow Jones and S&P 500 experienced their largest one day drop of 2018. The Dow Jones Industrial Average dropped 1.37 percent to close at 26,076.89, while the S&P 500 Index fell 1.09 percent to close at 2,822.43. The Nasdaq Composite Index declined 0.86 percent to close at 7,402.48. Investors appear to be awaiting details from the State of the Union address by President Donald Trump on Tuesday night.

“We’ve had a unilateral move higher [in stocks] to start things off and people are realizing this is not sustainable,” said Art Hogan, chief market strategist at B. Riley FBR. “You’re also seeing some cracks in the global story with interest rates rising.”

RDI Initiates Coverage on:

McDonald’s Corporation
https://rdinvesting.com/news/?ticker=MCD

Pfizer, Inc.
https://rdinvesting.com/news/?ticker=PFE

McDonald’s stock moved 2.98% lower Tuesday, to close the day at $172.48. The drop was despite the company beating sales and earnings estimates in its fourth quarter earnings. The company reported global comparable sales growth of 5.5%, beating the 4.9% that the street has been waiting for. The traders were probably worried by the addition of dollar menu that may weigh down the company’s future growth. The stock recorded a trading volume of 9,611,534 shares, which was above its three months average volume of 2,958,422 shares. In the last year, McDonald’s shares have traded in a range of 121.70 – 178.70. The share price has gained 41.73% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $173.94 is greater than its 200-day moving average of $164.51. Shares of the company are trading at a trailing Price to Earnings ratio of 24.96. Shares of McDonald’s have gained roughly 0.21 percent in the past month.

Access RDI’s McDonald’s Corporation Research Report at:
https://rdinvesting.com/news/?ticker=MCD

On Tuesday, shares of Pfizer recorded a trading volume of 45,998,017 shares, which was above the three months average volume of 16,893,696 shares. The stock ended the day 3.13% lower at $37.80 despite reporting better than expected Q4 earnings. EPS of $0.62 was well above the street’s estimates of $0.56. The stock declined as the company said it is expected to pay tax at about 17% in 2018 which was way above the street’s expectations. Last week, rival AbbVie had reported a much lower expected tax rate number of 9%. The share price has gained 22.21% from its 52-week low with a 52-week trading range of 30.93 – 39.43. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $36.79 is greater than its 200-day moving average of $35.29. Shares of the company are trading at a trailing Price to Earnings ratio of 23.35. Shares of Pfizer have gained roughly 4.36 percent in the past month.

Access RDI’s Pfizer, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=PFE

Our Actionable Research on McDonald’s Corporation (NYSE:MCD) and Pfizer, Inc. (NYSE:PFE) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 487448